CHAPTER 1 - MARKET SUMMARY
Market Overview
The New Zealand Mobility Aid Market serves users through publicly funded equipment programmes, injury rehabilitation schemes, institutional procurement and private retail. An estimated 17% of people living in New Zealand households were disabled in 2023, equivalent to 851,000 people. This creates recurring demand for walking supports, wheelchairs, mobility scooters, transfer equipment, replacement components and professional fitting services.
Auckland is the largest commercial demand centre because it combines the country's largest population base, tertiary hospitals, rehabilitation providers, aged-care facilities and specialist mobility retailers. National distribution remains important because equipment users are geographically dispersed. Suppliers therefore combine Auckland inventory with service coverage through regional branches, approved repair networks and contracted assessors operating across the North and South Islands.
Market Value
USD 122 million
2025
Dominant Region
Auckland
Dominant Segment
Powered Wheelchairs & Mobility Scooters
fastest growing
Total Number of Players
42
Future Outlook
The New Zealand Mobility Aid Market is projected to increase from USD 122 million in 2025 to USD 185 million by 2031. The resulting 7.19% forecast CAGR exceeds the 6.51% historical CAGR recorded during 2020–2025. Growth will be supported by a population aged 65 years and older approaching one million, longer periods of community-based living and expanding demand for configured powered mobility. Volume is projected to rise from approximately 110,000 mobility-aid units in 2025 to 150,000 units in 2031, while product mix shifts toward higher-value electronic, modular and customised equipment.
Government-funded demand will remain an anchor, but private-pay retail, aged-care procurement and replacement purchases will become more commercially important. Disability Support Services currently funds environmental support services for about 100,000 people annually, including approximately 50,000 recipients of equipment and modification services. Suppliers with national repair coverage, clinical configuration capabilities and access to approved product ranges will be positioned to capture premium profit pools. Inventory financing and foreign exchange exposure will remain constraints because most powered products and components are imported.
7.19%
Forecast CAGR
$185 Mn
2030 Projection
Base Year
2025
Historical Period
2020–2025
Forecast Period
2026–2031
Historical CAGR
6.51%
CHAPTER 2 - SCOPE OF REPORT
Scope of the Market
CHAPTER 3 - Key Stakeholders
Key Target Audience
Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning.
Investors
CAGR, recurring service revenue, working capital, procurement risk
Corporates
assortment mix, approved products, margins, regional coverage
Government
equipment access, lifecycle cost, equity, service outcomes
Operators
inventory turns, fitting capacity, repairs, technician productivity
Financial institutions
distributor finance, receivables, currency exposure, demand stability
CHAPTER 4 - Market Size & Growth
Market Size, Growth Forecast and Trends
This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers.
Historical & Projected Market Size ($ Million)
Year-over-Year Growth Rate (%)
Market Value vs Volume Growth (%)
Historical Market Performance (2020–2025)
Historical growth accelerated after 2021 as replacement demand recovered and suppliers restored access to imported equipment. The strongest annual increase occurred in 2023 at 7.00%, reflecting higher availability of powered mobility products and increased configuration revenue. Annual unit supply rose from approximately 86,000 units in 2020 to 110,000 in 2025. The blended selling price increased from USD 1,035 to USD 1,109 per unit as powered wheelchairs, specialised seating, batteries and customised components formed a larger proportion of expenditure.
Forecast Market Outlook (2026–2031)
The forecast period is expected to deliver 7.19% CAGR, with annual value growth remaining close to 7% throughout the period. Unit volume is projected to reach 150,000 by 2031, representing approximately 5.3% annual growth from 2025. Value growth will run ahead of volume because electrically powered and custom-configured products command materially higher prices than standard walking aids. Public funding will underpin clinical demand, while retail mobility scooters, lightweight travel wheelchairs and digitally fitted seating will expand the private-pay revenue pool.
CHAPTER 5 - Market Data
Market Breakdown
The market's transition toward powered and configurable mobility creates a value growth profile that exceeds underlying unit demand. The detailed KPI spine below highlights the interaction between annual equipment volume, public funding exposure and blended selling prices.
Year | Market Size (USD Mn) | YoY Growth (%) | Annual Units Supplied (000) | Government-Funded Demand Share (%) | Blended ASP (USD/Unit) | Period |
|---|---|---|---|---|---|---|
| 2020 | $89 Mn | +- | 86 | 58% | Forecast | |
| 2021 | $94 Mn | +5.62% | 90 | 59% | Forecast | |
| 2022 | $100 Mn | +6.38% | 95 | 59% | Forecast | |
| 2023 | $107 Mn | +7.00% | 100 | 60% | Forecast | |
| 2024 | $114 Mn | +6.54% | 105 | 60% | Forecast | |
| 2025 | $122 Mn | +7.02% | 110 | 61% | Forecast | |
| 2026 | $131 Mn | +7.38% | 116 | 61% | Forecast | |
| 2027 | $140 Mn | +6.87% | 122 | 60% | Forecast | |
| 2028 | $150 Mn | +7.14% | 128 | 60% | Forecast | |
| 2029 | $161 Mn | +7.33% | 135 | 59% | Forecast | |
| 2030 | $173 Mn | +7.45% | 142 | 59% | Forecast | |
| 2031 | $185 Mn | +6.94% | 150 | 58% | Forecast |
Annual Units Supplied
110,000 units, 2025, New Zealand. Volume reflects privately purchased equipment and products supplied through clinical funding pathways. Approximately 50,000 people receive publicly funded equipment and modification services annually, providing a recurring demand floor for approved products, repairs and replacements.
Government-Funded Demand Share
61%, 2025, New Zealand. Public procurement gives approved suppliers predictable order flows but creates tender, documentation and service obligations. Budget 2025 allocated average annual new operating expenditure of NZD 255 million to Disability Support Services, supporting system capacity while maintaining strong cost-control pressure.
Blended ASP
USD 1,109 per unit, 2025, New Zealand. The blended figure masks substantial category dispersion. Approved power-wheelchair configurations range from approximately NZD 5,000–6,000 for lower configurations to more than NZD 20,000 for complex powered systems, creating attractive configuration and after-sales revenue pools.
CHAPTER 6 - Segmentation
Market Segmentation Framework
Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns.
No of Segments
7
Dominant Segment
Product Type
Fastest Growing Segment
Technology
Product Type
Care Setting
End User
Application
Distribution Channel
Technology
Geography
Key Segmentation Takeaways
Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns.
Product Type
Product category is the primary revenue-allocation dimension because unit prices vary substantially between basic walking aids and complex powered wheelchairs. Powered Wheelchairs & Mobility Scooters generate the largest value pool through higher selling prices, battery replacement, electronics, configuration and servicing, while Walking Aids remain the largest category by unit volume.
Technology
Technology is the fastest-growing dimension as electronic controls, powered seating, remote diagnostics and modular customisation expand the addressable user base. Smart Connected and Sensor-Enabled products will grow from a small base, while Custom Modular and 3D-Fitted systems gain adoption among complex rehabilitation users requiring better pressure management, postural support and long-term adjustability.
CHAPTER 7 - Regional Analysis
Regional Analysis
New Zealand ranks behind Australia and Singapore but ahead of selected comparable small developed markets in the assessed peer set. Its position reflects a large disability-related demand base, national public funding pathways and high import dependence, while market scale remains constrained by population size.
Focus Country Ranking
3rd
Focus Country Market Size
USD 122 Mn
New Zealand CAGR (2026–2031)
7.19%
Focus Country Ranking
3rd
Focus Country Market Size
USD 122 Mn
New Zealand CAGR (2026–2031)
7.19%
Regional Analysis (Current Year)
Market Position
New Zealand ranks third among the five assessed peers, with its USD 122 million market supported by 851,000 disabled residents and nationally coordinated equipment-funding pathways.
Growth Advantage
New Zealand's 7.19% forecast CAGR exceeds Australia's 6.85%, Ireland's 6.60% and Finland's 5.90%, although it remains below Singapore's technology-led 7.80% trajectory.
Competitive Strengths
Approximately 50,000 publicly funded equipment recipients, established clinical-assessment networks and approved supplier lists support recurring demand, while 900,000 older residents strengthen private-pay mobility purchases.
CHAPTER 8 - INDUSTRY ANALYSIS
Growth Drivers, Challenges & Opportunities
Comprehensive analysis of key factors shaping the New Zealand Mobility Aid Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments.
Growth Drivers
Ageing Population and Independent Living Demand
- The population aged 65 years or older is expected to reach one million people (2028, New Zealand), increasing demand for rollators, manual wheelchairs, scooters and home-based transfer aids. Suppliers with accessible retail locations and home demonstrations can capture private-pay expenditure.
- Disability prevalence among older people was approximately 35% (2023, New Zealand), indicating that population ageing has a stronger impact on mobility demand than headline population growth. Product portfolios must cover progressive functional decline rather than only permanent severe disability.
- New Zealand's resident population reached 5.325 million people (June 2025, New Zealand). Even moderate penetration gains create meaningful equipment demand because mobility aids require periodic replacement, maintenance, battery renewal and reassessment as user needs change.
Public Equipment Funding and Unmet Need
- Environmental support programmes serve approximately 100,000 people annually (2025, New Zealand). Approved suppliers benefit from predictable referral pathways, while clinical assessment requirements favour companies able to provide demonstrations, fitting, documentation and post-delivery support.
- Approximately 62% of disabled people (2023, New Zealand) reported at least one unmet support need. The gap includes assistive equipment, care and accommodation, indicating latent demand that could be converted through faster assessments, flexible funding and lower-cost product formats.
- Budget 2025 included average annual new operating expenditure of NZD 255 million for Disability Support Services (2025, New Zealand). Funding supports system stability, but suppliers must demonstrate total-cost value because new appropriations also increase scrutiny of utilisation, procurement and service outcomes.
Premium Powered and Configured Mobility Adoption
- Lower-configuration powered wheelchairs are listed at approximately NZD 5,000–6,000 (2025, New Zealand), widening access to powered mobility while preserving room for distributor, fitting and maintenance revenue. Portfolio tiering allows suppliers to serve both standard and complex users.
- Enable New Zealand currently contracts four named suppliers (2026, New Zealand) for funded power-wheelchair supply in its regions. Approved-range participation creates an entry barrier and directs value toward suppliers with regulatory, clinical and technical-service capability.
- One major specialist distributor lists 51 mobility-scooter products (2026, New Zealand), illustrating the depth of private-retail assortment. Compact, foldable and travel-compatible equipment can expand demand beyond clinically funded users into lifestyle and convenience purchases.
Market Challenges
Import Dependence and Foreign Exchange Exposure
- Wheelchair imports increased from NZD 9.9 million in 2010 to NZD 15.4 million in 2019, before distribution and service margins. Import growth confirms limited domestic manufacturing depth and a reliance on international components, finished products and electronic systems.
- Powered wheelchairs contain batteries, motors, controllers and specialised seating sourced through global supply chains. A 5% landed-cost movement (planning sensitivity, 2025) can materially compress distributor margins when public procurement prices cannot be adjusted immediately.
- Suppliers must notify covered devices within 30 calendar days (current regulation, New Zealand) of becoming a sponsor. Overseas manufacturers without capable local sponsors face a practical market-access barrier covering traceability, device records, recalls and post-market communication.
Funding Constraints and Procurement Pressure
- Public programmes must balance volume growth, complex cases and product inflation within fixed appropriations. The addition of NZD 255 million average annual DSS operating expenditure (Budget 2025) supports capacity but does not remove the requirement for prioritisation and cost controls.
- ACC reported rehabilitation equipment expenditure running 8% favourable to budget (December 2025, New Zealand) following a lower cost per claim and product-mix changes. Procurement actions that improve scheme sustainability can reduce premium-product volumes or shift suppliers toward lower-cost configurations.
- ACC equipment expenditure was also 5% below the prior-year level (December 2025, New Zealand). Suppliers dependent on a single public funding channel therefore face revenue volatility and should diversify into private retail, aged care, maintenance and institutional contracts.
Regional Service and Repair Complexity
- Approximately 50,000 funded equipment recipients annually (2025, New Zealand) require assessment, fitting, repair and replacement coverage beyond major cities. Service delays can affect user safety and contract performance, making technician density a competitive differentiator.
- One national supplier operates from five listed regional locations (2026, New Zealand), illustrating the infrastructure required for national healthcare coverage. Smaller entrants may need authorised repair partners rather than wholly owned branches.
- High-configuration powered wheelchairs can exceed NZD 20,000 per unit (2025, New Zealand). Long repair cycles create significant user disruption and working-capital exposure, strengthening the value of spare-parts inventory, loan fleets and preventive maintenance contracts.
Market Opportunities
Refurbishment, Reissue and Lifecycle Services
- Monetizable angle, 2026–2031: suppliers can combine equipment sales with maintenance plans, battery replacement, sanitisation, seating reconfiguration and certified refurbishment, increasing revenue per installed unit while reducing dependence on new-product transactions.
- Beneficiary base, approximately 100,000 people annually: public funders gain lower lifecycle costs, users receive faster access and distributors improve workshop utilisation. Refurbished equipment is most viable where frames retain value but user-specific components can be replaced.
- Required change, service-level tracking from 2026: procurement frameworks must recognise residual asset value, standardise refurbishment quality and allow suppliers to recover logistics, inspection and warranty costs through transparent lifecycle pricing.
Smart Powered Mobility and Remote Diagnostics
- Monetizable angle, 7.19% market CAGR through 2031: remote fault alerts, battery-health monitoring, location services and configurable controls can support software-enabled servicing and reduce costly emergency technician visits.
- Who benefits, 851,000 disabled residents: users gain uptime and independence, funders gain visibility into equipment utilisation, and suppliers gain differentiated maintenance contracts and proprietary service data.
- Required change, approved-list integration during 2026–2031: connected features must demonstrate clinical benefit, privacy safeguards, repairability and compatibility with local service networks before public procurement can scale adoption.
Private Retail and Direct-to-Consumer Expansion
- Monetizable angle, 110,000 units in 2025: retailers can offer travel wheelchairs, rollators, portable scooters, accessories and home trials through omnichannel models, generating faster cash conversion than tender-funded complex equipment.
- Who benefits, 62% with unmet needs in 2023: users obtain quicker access to lower-complexity products, while specialist retailers capture demand not eligible for public funding.
- Required change, product education and finance options: retail growth depends on transparent specifications, safe fitting, instalment payment options and clear separation between self-selected aids and equipment requiring clinical prescription.
CHAPTER 9 - Competitive Landscape
Competitive Landscape Overview
Competition is moderately fragmented, with global manufacturers, New Zealand rehabilitation specialists, healthcare distributors and regional retailers competing through approved product access, clinical support, inventory availability and after-sales service.
Market Share Distribution
Top 5 Players
Market Dynamics
8 new entrants in the past 5 years, indicating strong market attractiveness and growth potential.
Company Name | Market Share | Headquarters | Founding Year | Core Market Focus |
|---|---|---|---|---|
Cubro Limited | - | Tauranga, New Zealand | - | Walking aids, wheelchairs, mobility equipment, aged-care and community-care products |
Allied Medical Limited | - | Auckland, New Zealand | - | Powered wheelchairs, mobility scooters, manual wheelchairs and daily-living aids |
Invacare New Zealand | - | Auckland, New Zealand | - | Powered mobility, manual wheelchairs, seating and rehabilitation equipment |
Medifab Limited | - | Auckland, New Zealand | 1990 | Complex rehabilitation technology, wheelchairs, custom seating and paediatric mobility |
Permobil New Zealand | - | Timrå, Sweden | 1967 | Premium powered wheelchairs, advanced seating and electronic mobility controls |
Morton & Perry Limited | - | Auckland, New Zealand | - | Powered wheelchairs, custom rehabilitation products and technical support |
Mobility Centre | - | - | - | Retail mobility scooters, wheelchairs, walkers and independent-living aids |
Goldfern Mobility | - | - | - | Mobility scooters, wheelchairs, walking aids, repairs and regional retail services |
BM Enterprises Limited | - | - | - | Assistive technology, rehabilitation equipment and mobility product distribution |
Medix 21 Limited | - | - | - | Healthcare equipment, mobility aids and rehabilitation product supply |
Cross Comparison Parameters
The report provides detailed cross-comparison of key players across 10 performance parameters to identify competitive strengths and weaknesses.
Approved Product Coverage
Service and Repair Turnaround
New Zealand Mobility Revenue Growth
Gross Margin on Equipment Sales
Analysis Covered
Market Share Analysis:
Estimates supplier positioning across funded, institutional and private retail channels
Cross Comparison Matrix:
Benchmarks approved ranges, service coverage, pricing and financial performance
SWOT Analysis:
Evaluates product access, technical capability, concentration risks and expansion options
Pricing Strategy Analysis:
Compares standard, premium, configured and lifecycle service pricing approaches
Company Profiles:
Reviews geographic presence, product focus, partnerships and market positioning
CHAPTER 10 - REPORT TOC
Table of Contents
Phase 1Market Assessment Phase
11
Chapters
Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.
Phase 2Go-To-Market Strategy Phase
15
Chapters
Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.
Complete Report Coverage
201+ detailed sections covering every aspect of the market
143
Assessment Sections
58
Strategy Sections
CHAPTER 11 - Our Approach
Research Methodology
Desk Research
- Reviewed disability prevalence and support needs
- Mapped funded equipment procurement pathways
- Analysed wheelchair import and pricing data
- Assessed supplier products and service coverage
Primary Research
- Interviewed occupational therapists and EMS assessors
- Consulted mobility distributor general managers
- Engaged rehabilitation equipment product managers
- Interviewed users and family caregivers
Validation and Triangulation
- Validated findings across 320 respondents
- Reconciled supplier and demand estimates
- Cross-checked volumes against import trends
- Tested pricing through product catalogues
CHAPTER 12 - FAQ
FAQs
Still have questions?
Our research team is here to help you find the right solution
CHAPTER 13 - Related Research
Explore Related Reports
Expand your market intelligence with complementary research across regions and adjacent markets.
Regional/Country ReportsRelated market analysis across key regions
Related market analysis across key regions
No regional reports found.
Adjacent ReportsRelated markets and complementary research
Related markets and complementary research
500+
Market Research Reports
50+
Countries Covered
15+
Industry Verticals